Kenvue Inc. $KVUE Shares Purchased by National Pension Service

National Pension Service lifted its stake in Kenvue Inc. (NYSE:KVUE) by 1.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 2,835,972 shares of the company’s stock after purchasing an additional 31,011 shares during the quarter. National Pension Service owned about 0.15% of Kenvue worth $48,921,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Cornerstone Planning Group LLC increased its holdings in shares of Kenvue by 705.2% in the third quarter. Cornerstone Planning Group LLC now owns 1,554 shares of the company’s stock valued at $25,000 after purchasing an additional 1,361 shares during the last quarter. Physician Wealth Advisors Inc. increased its holdings in shares of Kenvue by 67.5% in the fourth quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company’s stock valued at $26,000 after purchasing an additional 618 shares during the last quarter. Elyxium Wealth LLC acquired a new stake in shares of Kenvue in the fourth quarter valued at approximately $26,000. Golden State Wealth Management LLC increased its holdings in shares of Kenvue by 150.1% in the third quarter. Golden State Wealth Management LLC now owns 1,983 shares of the company’s stock valued at $32,000 after purchasing an additional 1,190 shares during the last quarter. Finally, SBI Securities Co. Ltd. increased its holdings in shares of Kenvue by 82.4% in the fourth quarter. SBI Securities Co. Ltd. now owns 2,273 shares of the company’s stock valued at $39,000 after purchasing an additional 1,027 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Insiders Place Their Bets

In related news, General Counsel Matthew Orlando sold 38,491 shares of the stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $17.66, for a total value of $679,751.06. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 1.59% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently commented on KVUE. Barclays cut their price target on Kenvue from $19.00 to $18.00 and set an “equal weight” rating for the company in a report on Tuesday, April 14th. UBS Group cut their price target on Kenvue from $19.00 to $18.00 and set a “neutral” rating for the company in a report on Tuesday, April 7th. Argus raised Kenvue to a “hold” rating in a report on Friday, March 6th. Canaccord Genuity Group increased their price target on Kenvue from $17.00 to $18.00 and gave the company a “hold” rating in a report on Wednesday, February 18th. Finally, Weiss Ratings lowered Kenvue from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and twelve have issued a Hold rating to the stock. According to data from MarketBeat.com, Kenvue currently has a consensus rating of “Hold” and an average price target of $19.33.

Kenvue Trading Up 0.0%

Shares of Kenvue stock opened at $17.29 on Monday. The firm has a market capitalization of $33.19 billion, a price-to-earnings ratio of 20.34, a PEG ratio of 1.31 and a beta of 0.54. Kenvue Inc. has a fifty-two week low of $14.02 and a fifty-two week high of $23.90. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.70 and a current ratio of 0.98. The stock has a 50 day moving average of $17.40 and a 200 day moving average of $17.46.

Kenvue (NYSE:KVUE) last issued its quarterly earnings data on Thursday, May 7th. The company reported $0.32 earnings per share for the quarter, topping the consensus estimate of $0.27 by $0.05. The company had revenue of $3.91 billion during the quarter, compared to analyst estimates of $3.84 billion. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.The firm’s revenue for the quarter was up 4.5% compared to the same quarter last year. During the same period in the prior year, the business posted $0.24 earnings per share. As a group, research analysts predict that Kenvue Inc. will post 1.16 earnings per share for the current year.

Kenvue Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, May 27th. Investors of record on Wednesday, May 13th were given a $0.2075 dividend. This represents a $0.83 annualized dividend and a yield of 4.8%. The ex-dividend date was Wednesday, May 13th. Kenvue’s dividend payout ratio is presently 97.65%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.